DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Clinical Chemistry Analyzers Market 2017-2021" report to their offering.
The global clinical chemistry analyzers market to grow at a CAGR of 2.24% during the period 2017-2021.
The report, Global Clinical Chemistry Analyzers Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is focus on fully automated clinical chemistry analyzers. In the last few years, clinical chemistry analyzers have been undergoing major changes in design and function. Typically, the POC monitoring of anticoagulation is done in outpatient anticoagulation clinics, cardiac surgery units, intensive care units (ICUs), and dialysis units with the help of different technologies. There are fully automated clinical chemistry analyzers available in the market that can perform functions such as recognition of sample and reagent bottles, tube sampling, cap piercing, automatic re-run, and dilution.
According to the report, one of the major drivers for this market is rising demand for automation and integration of multiple processes. Clinical laboratories rely on progressing levels of automation to solve persistent challenges that include lack of skilled personnel, pressures to maintain cost while increasing productivity, and errors associated with manual processes.
- Abbott Laboratories
- F. Hoffmann-La Roche
Thermo Fisher Scientific
Other prominent vendors
- Analytik Jena
- BioSystems Diagnostics
- DiaSys Diagnostic Systems
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by product
PART 07: Market segmentation by end-users
PART 08: Geographical segmentation
PART 09: Decision framework
PART 10: Drivers and challenges
PART 11: Market trends
PART 12: Vendor landscape
PART 13: Key vendor analysis
PART 14: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/bhsz8m/global_clinical